ARGOS THERAPEUTICS INC — key financial figures for fiscal year 2017 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2017)

$1.9M

Net Income/Loss (FY2017)

-$40.6M

Total Assets (FY2017)

$20.8M

Total Equity (FY2017)

-$9.2M

Cash Flows from Operating Activities (FY2017)

-$35.4M

Source: ARGOS THERAPEUTICS INC 10-K filing (FY2017). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.